Company Description
Actelion walks a fine line. The company discovers and develops drugs based on its research of the endothelium, the single layer of cells between...
Key Actelion Financials
| Company Type | Public - Swiss: ATLN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $1,317.4 |
| 2007 Employees | 1,640 |
More Actelion Financials (3 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Actelion's competition across multiple industries
Top Actelion Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Actelion Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Robert E. (Rob) Cawthorn | Network | E-mail |
| CEO and Director | Jean-Paul Clozel | Network | E-mail |
| VP, Head of Investor Relations and Public Affairs | Roland Häefeli | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Actelion News
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.